Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 03 Sept 2026 for CORCEPT THERAPEUTICS INC, €13k. Read the official filing
Filing timeline
BuySaleAtabak Mokari
Insider track record
Disclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Atabak Mokari: trading record in brief
Atabak Mokari discloses dealings in Corcept Therapeutics Inc to SEC (Form 4). Between 1 September 2022 and 2 September 2026, the trades on record add up to 46 filings.
On the market, this insider has only sold: 22 sales, €13.5M in total. The totals exclude 4 filings filed without an amount. Outside the open market, there are 19 share grants and 5 option exercises. Since January 2026: no purchases and 22 sales on the market.
The record was last updated on 3 September 2026 with a share grant in Corcept Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Atabak Mokari
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
138 shares@ US$113.38Common StockSEC:0001193125-26-382463:0
138 shares0Common StockSEC:0001193125-26-382463:1
102 shares@ US$113.38Common StockSEC:0001193125-26-382463:2
7,089 shares@ US$116.95610.0067% mcap4.3% of flowCommon StockSEC:0001193125-26-330668:9
400 shares@ US$108.460.0004% mcap0.2% of flowCommon StockSEC:0001193125-26-330668:3
8,103 shares@ US$119.94810.0079% mcap5.0% of flowCommon StockSEC:0001193125-26-330668:12
1,001 shares@ US$120.67490.0010% mcap0.6% of flowCommon StockSEC:0001193125-26-330668:13
14,222 shares@ US$115.86690.013% mcap8.6% of flowCommon StockSEC:0001193125-26-330668:8
2,202 shares@ US$110.02830.0020% mcap1.3% of flowCommon StockSEC:0001193125-26-330668:4
80,000 shares@ US$23.060.015% mcap9.6% of flowCommon StockSEC:0001193125-26-330668:0
4,200 shares@ US$105.53520.0036% mcap2.3% of flowCommon StockSEC:0001193125-26-330668:1
8,956 shares@ US$106.95530.0078% mcap5.0% of flowCommon StockSEC:0001193125-26-330668:2
600 shares@ US$110.950.0005% mcap0.3% of flowCommon StockSEC:0001193125-26-330668:5
4,700 shares@ US$113.17890.0043% mcap2.8% of flowCommon StockSEC:0001193125-26-330668:6
15,477 shares@ US$114.96010.014% mcap9.2% of flowCommon StockSEC:0001193125-26-330668:7
8,267 shares@ US$117.93290.0079% mcap5.1% of flowCommon StockSEC:0001193125-26-330668:10
4,783 shares@ US$118.73460.0046% mcap2.9% of flowCommon StockSEC:0001193125-26-330668:11
3,520 shares@ US$88.30160.0025% mcap3.8% of flowCommon StockSEC:0001193125-26-308058:4
15,833 shares@ US$19.260.0025% mcap3.7% of flowCommon StockSEC:0001193125-26-308058:0
101 shares@ US$89.42820.0001% mcap0.1% of flowCommon StockSEC:0001193125-26-308058:5
28,460 shares@ US$87.88630.020% mcap30.4% of flowCommon StockSEC:0001193125-26-308058:3
7,919 shares@ US$86.7760.0055% mcap8.3% of flowCommon StockSEC:0001193125-26-308058:2
24,167 shares@ US$23.060.0045% mcap6.8% of flowCommon StockSEC:0001193125-26-308058:1
40,000 sharesCommon StockSEC:0001193125-26-274224:0
9,434 sharesCommon StockSEC:0001193125-26-274224:1
25 of 46 declarations
